Aastrom management update

Aastrom Biosciences Inc. (NASDAQ: ASTM), Ann Arbor, Mich. Business: Gene/Cell therapy Transitioning: Dan Orlando, chief commercial officer, to interim CEO, effective Dec. 14; he replaces Tim Mayleben,...